rs745834030

Variant summary

Our verdict is Uncertain significance. Variant got 3 ACMG points: 4P and 1B. PM1PM5BS2_Supporting

The NM_000371.4(TTR):​c.370C>T​(p.Arg124Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000248 in 1,614,076 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R124H) has been classified as Pathogenic.

Frequency

Genomes: 𝑓 0.000046 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000023 ( 0 hom. )

Consequence

TTR
NM_000371.4 missense

Scores

3
8
8

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:11

Conservation

PhyloP100: 3.43
Variant links:
Genes affected
TTR (HGNC:12405): (transthyretin) This gene encodes one of the three prealbumins, which include alpha-1-antitrypsin, transthyretin and orosomucoid. The encoded protein, transthyretin, is a homo-tetrameric carrier protein, which transports thyroid hormones in the plasma and cerebrospinal fluid. It is also involved in the transport of retinol (vitamin A) in the plasma by associating with retinol-binding protein. The protein may also be involved in other intracellular processes including proteolysis, nerve regeneration, autophagy and glucose homeostasis. Mutations in this gene are associated with amyloid deposition, predominantly affecting peripheral nerves or the heart, while a small percentage of the gene mutations are non-amyloidogenic. The mutations are implicated in the etiology of several diseases, including amyloidotic polyneuropathy, euthyroid hyperthyroxinaemia, amyloidotic vitreous opacities, cardiomyopathy, oculoleptomeningeal amyloidosis, meningocerebrovascular amyloidosis and carpal tunnel syndrome. [provided by RefSeq, Aug 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 3 ACMG points.

PM1
In a chain Transthyretin (size 126) in uniprot entity TTHY_HUMAN there are 141 pathogenic changes around while only 6 benign (96%) in NM_000371.4
PM5
Other missense variant is known to change same aminoacid residue: Variant chr18-31598602-G-A is described in Lovd as [Pathogenic].
BS2
High AC in GnomAd4 at 7 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TTRNM_000371.4 linkuse as main transcriptc.370C>T p.Arg124Cys missense_variant 4/4 ENST00000237014.8 NP_000362.1
LOC124904277XR_007066326.1 linkuse as main transcriptn.129-2906G>A intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TTRENST00000237014.8 linkuse as main transcriptc.370C>T p.Arg124Cys missense_variant 4/41 NM_000371.4 ENSP00000237014 P1
TTRENST00000649620.1 linkuse as main transcriptc.370C>T p.Arg124Cys missense_variant 6/6 ENSP00000497927 P1
TTRENST00000610404.5 linkuse as main transcriptc.274C>T p.Arg92Cys missense_variant 4/45 ENSP00000477599

Frequencies

GnomAD3 genomes
AF:
0.0000460
AC:
7
AN:
152202
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000517
AC:
13
AN:
251388
Hom.:
1
AF XY:
0.0000662
AC XY:
9
AN XY:
135866
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000435
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000463
Gnomad NFE exome
AF:
0.0000352
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000226
AC:
33
AN:
1461874
Hom.:
0
Cov.:
31
AF XY:
0.0000330
AC XY:
24
AN XY:
727240
show subpopulations
Gnomad4 AFR exome
AF:
0.0000597
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000227
Gnomad4 SAS exome
AF:
0.0000232
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000117
Gnomad4 OTH exome
AF:
0.000116
GnomAD4 genome
AF:
0.0000460
AC:
7
AN:
152202
Hom.:
0
Cov.:
33
AF XY:
0.0000134
AC XY:
1
AN XY:
74360
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.000262
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000385
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000378
ExAC
AF:
0.0000412
AC:
5
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingAthena DiagnosticsNov 30, 2016- -
Uncertain significance, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpMay 24, 2024Variant summary: TTR c.370C>T (p.Arg124Cys) results in a non-conservative amino acid change located in the Transthyretin/hydroxyisourate hydrolase domain (IPR023416) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2.5e-05 in 1614076 control chromosomes, predominantly at a frequency of 0.00024 within the East Asian subpopulation in the gnomAD database. The observed variant frequency within East Asian control individuals in the gnomAD database is approximately 7.68 fold of the estimated maximal expected allele frequency for a pathogenic variant in TTR causing Transthyretin Amyloidosis phenotype (3.1e-05). c.370C>T has been reported in the literature in individuals with clinical features of TTR-related contions (e.g., Saraiva_1999; Maurizi_2020). It has also been identified as a variant of uncertain significance in 6 individuals from a whole exome cohort with unclear phenotypes (e.g., Abouelhoda_2021). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 31371117, 10439123, 34380564). ClinVar contains an entry for this variant (Variation ID: 404412). Based on the evidence outlined above, the variant was classified as VUS-possibly benign. -
not provided Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingBlueprint GeneticsFeb 19, 2018- -
Uncertain significance, criteria provided, single submitterclinical testingGeneDxNov 14, 2022Identified in an individual with sensory axonal neuropathy in the published literature (Torres et al., 1996); Reported in a patient with cardiac amyloidosis (Maurizi et al., 2020) and a patient with CMT in the published literature (Volodarsky et al., 2021); In silico analysis supports that this missense variant does not alter protein structure/function; Also known as Cys 104; This variant is associated with the following publications: (PMID: 31371117, 32376792, 33192475, 34380564, 35903975) -
Charcot-Marie-Tooth disease Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingMolecular Genetics Laboratory, London Health Sciences Centre-- -
Cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingCHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern OntarioNov 02, 2021- -
Hyperthyroxinemia, dystransthyretinemic;C2751492:Amyloidosis, hereditary systemic 1;C5779776:Carpal tunnel syndrome 1 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsMay 25, 2022- -
Conduction disorder of the heart Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingMolecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart InstituteOct 22, 2019- -
Brugada syndrome Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingCenter for Advanced Laboratory Medicine, UC San Diego Health, University of California San DiegoJan 17, 2019- -
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 12, 2022The p.R124C variant (also known as c.370C>T), located in coding exon 4 of the TTR gene, results from a C to T substitution at nucleotide position 370. The arginine at codon 124 is replaced by cysteine, an amino acid with highly dissimilar properties. This alteration, which is also known as p.R104C, has been reported in a hypertrophic cardiomyopathy (HCM) cohort (Mazzarotto F et al. Genet Med, 2019 02;21:284-292; Maurizi N et al. Int J Cardiol, 2020 02;300:191-195). Additionally, this alteration was detected in an individual with neuropathy who was not found to have amyloid deposits in muscle or nerve biopsies, and an in vitro assay showed this alteration may not impact protein function (Grether NB et al. Ann Clin Transl Neurol, 2022 08;9:1252-1263). This amino acid position is poorly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Amyloidosis, hereditary systemic 1 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpDec 22, 2023This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 124 of the TTR protein (p.Arg124Cys). This variant is present in population databases (rs745834030, gnomAD 0.04%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with cardiac amyloidosis and/or sensory axonal neuropathy (PMID: 10439123, 31371117). This variant is also known as Arg104Cys. ClinVar contains an entry for this variant (Variation ID: 404412). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TTR protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.26
BayesDel_addAF
Benign
-0.012
T
BayesDel_noAF
Uncertain
0.080
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.89
D;D;T;.
Eigen
Benign
0.13
Eigen_PC
Benign
0.016
FATHMM_MKL
Uncertain
0.87
D
LIST_S2
Uncertain
0.93
.;D;T;D
M_CAP
Pathogenic
0.30
D
MetaRNN
Uncertain
0.52
D;D;D;D
MetaSVM
Uncertain
0.46
D
MutationAssessor
Benign
0.81
L;L;.;.
MutationTaster
Benign
0.99
N
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-2.3
.;N;.;.
REVEL
Uncertain
0.53
Sift
Pathogenic
0.0
.;D;.;.
Sift4G
Uncertain
0.0020
.;D;D;D
Polyphen
0.95
P;P;.;.
Vest4
0.32, 0.54, 0.35
MutPred
0.52
Loss of disorder (P = 0.0407);Loss of disorder (P = 0.0407);Loss of disorder (P = 0.0407);.;
MVP
0.98
MPC
1.6
ClinPred
0.32
T
GERP RS
4.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.32
gMVP
0.86

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs745834030; hg19: chr18-29178564; COSMIC: COSV52700989; COSMIC: COSV52700989; API